4.5 Article

ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism

期刊

GENOME BIOLOGY
卷 22, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13059-021-02271-9

关键词

-

资金

  1. AIRC (Associazione Italiana Ricerca sul Cancro) IG grants [13202]
  2. Fondazione Mia Neri

向作者/读者索取更多资源

The study reveals that METTL3 methylates ADAR1 mRNA and increases its protein level, linking m6A and A-to-I editing and promoting glioblastoma growth. ADAR1 plays a crucial role in cancer progression and its knockdown can strongly inhibit glioblastoma growth.
Background N-6-methyladenosine (m6A) and adenosine-to-inosine (A-to-I) RNA editing are two of the most abundant RNA modification events affecting adenosines in mammals. Both these RNA modifications determine mRNA fate and play a pivotal role in tumor development and progression. Results Here, we show that METTL3, upregulated in glioblastoma, methylates ADAR1 mRNA and increases its protein level leading to a pro-tumorigenic mechanism connecting METTL3, YTHDF1, and ADAR1. We show that ADAR1 plays a cancer-promoting role independently of its deaminase activity by binding CDK2 mRNA, underlining the importance of ADARs as essential RNA-binding proteins for cell homeostasis as well as cancer progression. Additionally, we show that ADAR1 knockdown is sufficient to strongly inhibit glioblastoma growth in vivo. Conclusions Hence, our findings underscore METTL3/ADAR1 axis as a novel crucial pathway in cancer progression that connects m6A and A-to-I editing post-transcriptional events.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据